TY - JOUR
T1 - Relationship between DNA Methylation in the 59 CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Livers
AU - Tanaka, Toshihiro
AU - Hirota, Takeshi
AU - Ieiri, Ichiro
N1 - Funding Information:
This work was supported by the Japan Society for the Promotion of Science [KAKENHI Grant-in-Aid for Scientific Research (C) 17H04103 The authors appreciate the technical assistance provided by the Research Support Center and Research Center for Human Disease Modeling at Kyushu University Graduate School of Medical Sciences.
Funding Information:
This work was supported by the Japan Society for the Promotion of Science [KAKENHI Grant-in-Aid for Scientific Research (C) 17H04103]. https://doi.org/10.1124/mol.117.109553. s This article has supplemental material available at molpharm. aspetjournals.org.
Publisher Copyright:
© 2017 by The American Society for Pharmacology and Experimental Therapeutics
PY - 2018/1
Y1 - 2018/1
N2 - Multidrug and toxin extrusion protein 1 (MATE1), which is encoded by solute carrier 47A1 (SLC47A1), mediates the excretion of organic cations into bile and urine. Some genetic variants in human MATE1 altered its transport function in in vitro experiments; however, differences in the pharmacokinetics of substrate drugs cannot be explained by genetic variations in humans. In this study, we investigated whether DNA methylation was involved in interindividual variability in MATE1 expression in the human liver. Approximately 20-fold interindividual variability in MATE1 mRNA expression levels was observed in liver samples and mRNA expression levels negatively correlated with methylation levels of the CpG island in the 27 kb upstream of SLC47A1. DNA demethylation by treatment with 5-aza-29-deoxycytidine increased MATE1 mRNA expression in MATE1-negative cell lines. The luciferase reporter assay showed that the CpG island increased the transcriptional activity of the SLC47A1 promoter. MATE1 mRNA expression levels were significantly lower in CpG island knockout HepG2 cells than in control cells. These results suggest that the 59 CpG island of SLC47A1 acts as an enhancer for SLC47A1, and DNA methylation in the CpG island plays an important role in interindividual differences in hepatic MATE1 expression.
AB - Multidrug and toxin extrusion protein 1 (MATE1), which is encoded by solute carrier 47A1 (SLC47A1), mediates the excretion of organic cations into bile and urine. Some genetic variants in human MATE1 altered its transport function in in vitro experiments; however, differences in the pharmacokinetics of substrate drugs cannot be explained by genetic variations in humans. In this study, we investigated whether DNA methylation was involved in interindividual variability in MATE1 expression in the human liver. Approximately 20-fold interindividual variability in MATE1 mRNA expression levels was observed in liver samples and mRNA expression levels negatively correlated with methylation levels of the CpG island in the 27 kb upstream of SLC47A1. DNA demethylation by treatment with 5-aza-29-deoxycytidine increased MATE1 mRNA expression in MATE1-negative cell lines. The luciferase reporter assay showed that the CpG island increased the transcriptional activity of the SLC47A1 promoter. MATE1 mRNA expression levels were significantly lower in CpG island knockout HepG2 cells than in control cells. These results suggest that the 59 CpG island of SLC47A1 acts as an enhancer for SLC47A1, and DNA methylation in the CpG island plays an important role in interindividual differences in hepatic MATE1 expression.
UR - http://www.scopus.com/inward/record.url?scp=85038129722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038129722&partnerID=8YFLogxK
U2 - 10.1124/mol.117.109553
DO - 10.1124/mol.117.109553
M3 - Article
C2 - 29070695
AN - SCOPUS:85038129722
SN - 0026-895X
VL - 93
SP - 1
EP - 7
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 1
ER -